Clinical Trial Update: INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on an influenza vaccine aimed at reducing cardiovascular events in patients with heart failure and prior myocardial infarction; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Heart Failure, Myocardial Infarction | Phase 4 | Status: COMPLETED | Results posted: 2021-09-14